Investment Management Corp of Ontario (IMCO)’s Regeneron Pharmaceuticals REGN Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.77M	Sell	7,642 -322	-4%	-$219K	0.06%	272
2026 Q1	$6.15M	Sell	7,964 -1,242	-13%	-$951K	0.08%	228
2025 Q4	$7.11M	Buy	9,206 +2,050	+29%	+$1.39M	0.09%	172
2025 Q3	$4.02M	Buy	7,156 +2,407	+51%	+$1.36M	0.06%	225
2025 Q2	$2.49M	Sell	4,749 -500	-10%	-$279K	0.04%	271
2025 Q1	$3.33M	Buy	5,249 +100	+2%	+$68.8K	0.07%	220
2024 Q4	$3.67M	Buy	5,149 +1,562	+44%	+$1.31M	0.12%	109
2024 Q3	$3.77M	Buy	3,587 +1,200	+50%	+$1.34M	0.08%	167
2024 Q2	$2.51M	Buy	2,387 +700	+41%	+$679K	0.07%	193
2024 Q1	$1.62M	Sell	1,687 -800	-32%	-$761K	0.05%	232
2023 Q4	$2.18M	Buy	+2,487	New	+$2.05M	0.05%	230
2023 Q1	–	Sell	-1,434	Closed	-$1.03M	–	207
2022 Q4	$1.03M	Buy	+1,434	New	+$1.06M	0.05%	147

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s REGN Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Regeneron Pharmaceuticals (REGN) stake by 4% in Q2 2026, selling an estimated $219K and leaving 7,642 shares worth $4.77M. The position accounts for 0.06% of the portfolio, ranked #272.

Investment Management Corp of Ontario (IMCO) first reported a position in REGN in Q4 2022 and has held it in 12 quarters since. The position peaked at $7.11M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Investment Management Corp of Ontario (IMCO) held 7,642 shares of Regeneron Pharmaceuticals worth $4.77M as of Q2 2026.
Investment Management Corp of Ontario (IMCO) sold 322 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $219K.
Regeneron Pharmaceuticals made up 0.06% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #272 holding.
Investment Management Corp of Ontario (IMCO) first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
Investment Management Corp of Ontario (IMCO)'s Regeneron Pharmaceuticals position peaked at $7.11M in Q4 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.